SoftBank's AI Ambitions Hit a Valuation Reckoning as Shares Slide 16%
BASF's $1 Billion Geismar Bet Takes Center Stage After Evonik Talks Collapse
Bayer's Roundup Cap Is Court-Approved, but the Payment Clock Still Hasn't Started
Deutz's FFG Defence Bet Meets Its Real Test: Not Order Flow, but Who Books the Profit
Brussels Clears UniCredit's Path to Commerzbank, but the Integration Blueprint Stays Blank
Leverage Washout Meets a Weekend Rebound: What Bitcoin's Violent Swing Actually Tells Us
Alibaba's AI Cloud Surge Comes With a 34.47 Billion Yuan Cash Drain
Standard Lithium's $1.2 Billion Ambition Meets a Lower Bar on Wall Street
Lenovo's US$80 Billion Pipeline Meets a US$640 Million Accounting Loss
SoftBank's ABB Robotics Deal Hits a Chinese Wall as AI Doubts Weigh on the Stock
Volkswagen Ties Weekly Hours to Plant Utilisation as Emden Talks Open Under a Cloud of Losses
OpenAI Partnership Cuts Both Ways for LVMH as Dior Reshapes the Group's Ownership
ams-OSRAM's Real Test: Can Margins Hold If Revenue Slips?
Siemens Looks Past AI-Driven Slide to Nuremberg as Analysts Split on the Recovery Case
XPeng's Malaysia Exit and HSBC Downgrade Put Q4 Delivery Guidance Under a Microscope
A Geberit Works Council Member Said No to €80,000. Now a Judge Could Hand Him Nothing.
SoftBank Walks Back SK Hynix Takeover Talk as Investors Refocus on Memory Pricing
Micron's 14% Slide Puts Memory Pricing and a Revived Lawsuit on the Same Calendar
Voestalpine's Grid Connection Lands as Traders Weigh What Survives of the Profit Jump
Xiaomi Faces a Twin Test: JPMorgan's Deep Profit Cut and India's Tax Claim
Partners Group Slips as EdgeCore Sale Talk Meets a Wall of Broker Caution
Lenzing's Heiligenkreuz Deadline Looms as Berenberg Trims Target and Goldman Cuts Stake
SAP CFO Signals Smaller Workforce Ahead as AI Reshapes Headcount Plans
AMD's China Exposure Back in the Dock as Short-Seller Report Triggers Legal Scrutiny
Deutz Heads Into a Packed Investor Calendar With One Question Still Unanswered on FFG
BYD Appeals EU-Wide Ti7 Ban as Daiwa Slashes 2026 Sales Forecast
Evonik Turns to Oxeno Sale as BASF Exit Leaves a 24-Euro Marker
Buyers Pile Into Vanguard's All-World ETF Even as a Seventh Straight Global Decline Bites
Novo Nordisk's CagriSema Filing Heads for Q4 2026 FDA Verdict as EU Clears Frehemgo
Oracle Has the OpenAI Money in Hand; Now the Concrete Has to Catch Up